Bowel cancer cases in young people rising sharply in England, study finds Experts believe poor diet, more ultra-processed foods, obesity and a lack of exercise are playing a role. The Independent UK · Dec 11, 2024
2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside. Barchart · Dec 8, 2024
Life expectancy in U.S. could stall by 2050 because America is getting too fat, physicians warn Rising rates of obesity and drug use deaths are forecast to contribute to future life expectancy The Independent UK · Dec 6, 2024
WATCH: Vince Papale talks tackling obesity, ROCKY-Run, and Eagles Super Bowl hopes Vince Papale sat down with The Eagles Wire to talk about how he tackled obesity, his beautiful wife Janet Kent, his talented son and UFL receiver Vinny Papale, and whether Nick Sirianni's team has what it takes to win a Super Bowl. USA Today Sports Media Group · Dec 5, 2024
Is Zepbound or Wegovy better for weight loss? New clinical trial reveals which medication sheds more pounds Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Fortune · Dec 4, 2024
Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says In the first head-to-head test, people using Eli Lilly’s Zepbound lost just over 50 pounds while those using competitor Novo Nordisk’s Wegovy shed more than 33 pounds The Independent UK · Dec 4, 2024
Porridge and crumpets among list of breakfast foods in anti-obesity ban The ban will come into effect in October 2025 and includes croissants and protein bars The Independent UK · Dec 3, 2024
Sugary porridge and crumpets among food products in anti-obesity advertising ban The ban, which will come into effect in October 2025, will mean ‘unhealthy’ products cannot be advertised before the watershed. Evening Standard · Dec 3, 2024
Junk food advert ban ‘will prevent 20,000 cases of childhood obesity’ The ban will come into force next October The Independent UK · Dec 3, 2024
Junk food ad ban ‘will prevent an estimated 20,000 cases of childhood obesity’ The Government confirmed the laying of secondary legislation for the ban on Tuesday. Evening Standard · Dec 3, 2024
Jamie Oliver launches campaign to target child obesity at London primary schools The popular TV chef will deliver his Ministry of Food programme with Hounslow Council Evening Standard · Dec 2, 2024
France's proposed new sugar tax could transform the biggest food companies—will the consumer pay the price? In the fight against obesity and the need to raise revenue for a seriously impoverished economy, one policy idea is to tax these sugary, highly processed products. Fortune · Dec 1, 2024
Ozempic-like drugs may treat alcohol addiction, study finds A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, adding to a body of work suggesting these drugs could potentially be used to manage addiction. LiveScience · Nov 30, 2024
Fat cells have a 'memory' of obesity, study finds Most people who lose weight through dieting will see it creep back up, leading to a cycle of "yo-yo dieting" that's hard on the body. A new study suggests fat cells keep a memory of previous weight gain, which may help to explain why this happens. LiveScience · Nov 29, 2024
The Times of India · Nov 28, 2024 Why are one in four young Indians now affected by Type 2 Diabetes? India is currently witnessing a massive rise in Type 2 diabetes (T2D) cases among its youth, with every one in four young people aged 15-24 affected now. The number of young people diagnosed with type 2 diabetes (T2D) has nearly doubled in just 15 years. Back in 2002, about 9…
The Conversation · Nov 28, 2024 Why some people don’t lose weight with Wegovy Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don’t work for everyone.
The Conversation · Nov 27, 2024 208 million Americans are classified as obese or overweight, according to new study synthesizing 132 data sources Nearly half of adolescents and three-quarters of adults in the U.S. were classified as being clinically overweight or obese in 2021. The rates have more than doubled compared with 1990.
Top News · Nov 27, 2024 Biden Administration Proposes Expanded Coverage For Anti-Obesity Drugs Biden administration proposes expanding coverage for anti-obesity drugs to millions of Medicare and Medicaid beneficiaries, potentially reducing out-of-poc...
The Independent UK · Nov 26, 2024 Cheap Ozempic? Millions of obese Americans wait on Trump’s decision Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump.
Benzinga · Nov 26, 2024 Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs The Biden Administration's proposal expands Medicare and Medicaid coverage for anti-obesity drugs, cutting costs for millions while addressing the obesity crisis.
Benzinga · Nov 26, 2024 Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau Amgen's Phase 2 MariTide trial showed ~20% weight loss at 52 weeks, cardiometabolic improvements, and no significant safety issues.
Top News · Nov 26, 2024 Biden Administration Proposes Expanded Coverage For Anti-Obesity Drugs Biden administration proposes expanding coverage for anti-obesity drugs to millions, potentially reducing costs for vulnerable populations.
Fortune · Nov 26, 2024 Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ to Denmark’s economy Novo Nordisk Foundation CEO Mads Krogsgaard Thomsen said only 9 million people are using GLP-1s compared with 1 billion people living with obesity.
Roll Call · Nov 26, 2024 White House rule would expand coverage of anti-obesity drugs - Roll Call It’s unclear whether incoming President Donald J. Trump will support outgoing President Joe Biden’s plan to insure the weight loss drugs.
The Independent UK · Nov 26, 2024 Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning